Ajay Samkaria: Prevention of Alloimmunization in Females of Childbearing Age
Ajay Samkaria, Product and Application Manager at Diagast Transfusion Medicine, shared a post on LinkedIn:
“In transfusion medicine, prevention is always better than reaction.
One of the most critical yet often under-emphasized practices is extended phenotyping – especially for Rh (C, c, E, e) and Kell antigens in females.
Why does this matter?
Because alloimmunization doesn’t just affect a single transfusion – it can impact future pregnancies and neonatal outcomes.
A young female patient exposed to mismatched Rh or Kell antigens today may develop clinically significant antibodies tomorrow.
These antibodies can lead to Hemolytic Disease of the Fetus and Newborn (HDFN), posing serious risks to both mother and baby.
By proactively providing Rh and Kell matched blood for females of childbearing age, we are not just ensuring safe transfusion – we are protecting future lives.
This is not just good practice.
It is responsible transfusion medicine.
Let’s move from compatibility to foresight.”
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria